Phenotypic and clinical manifestations of compound heterozygous genetic haemochromatosis (CHGH): a non‐invasive approach to clinical management

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Internal medicine journal (Print)

• Publication date

  2013-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1445-5994.2012.02937.xPMID 22957807
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants

  2011cited by this paper
• Hemochromatosis genotypes and risk of iron overload--a meta-analysis.

  2011cited by this paper
• Advanced MRI methods for assessment of chronic liver disease.

  2009cited by this paper
• The metabolic syndrome: common origins of a multifactorial disorder

  2009cited by this paper
• HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis‐related morbidity

  2009cited by this paper
• Iron-Overload-Related Disease in HFE Hereditary Hemochromatosis

  2008cited by this paper
• Hyperferritinemia Is Associated with Insulin Resistance and Fatty Liver in Patients without Iron Overload

  2008cited by this paper
• Iron-overload-related disease in HFE hereditary hemochromatosis.

  2008cited by this paper
• Global sequencing approach for characterizing the molecular background of hereditary iron disorders.

  2007cited by this paper
• Incidence and natural course of fatty liver in the general population: The Dionysos study

  2007cited by this paper
• Guidelines for the assessment and management of non‐alcoholic fatty liver disease in the Asia–Pacific region: Executive summary

  2007cited by this paper
• Nonalcoholic fatty liver disease.

  2006cited by this paper
• Hereditary hemochromatosis.

  2006cited by this paper
• The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.

  2006cited by this paper
• Hemochromatosis with mutation of the ferroportin 1 (IREG1) gene.

  2005cited by this paper
• Hepatic iron loading in patients with compound heterozygous HFE mutations

  2004cited by this paper
• Evolution of untreated hereditary hemochromatosis in the Busselton population: a 17-year study.

  2004cited by this paper
• Serum Ferritin Level Predicts Advanced Hepatic Fibrosis among U.S. Patients with Phenotypic Hemochromatosis

  2003cited by this paper
• A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation.

  2002cited by this paper
• Liver pathology in compound heterozygous patients for hemochromatosis mutations.

  2002cited by this paper
• Noninvasive prediction of cirrhosis in C282Y‐linked hemochromatosis

  2002cited by this paper
• Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States.

  2001cited by this paper
• Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives.

  1999cited by this paper
• Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation.

  1998cited by this paper
• Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

  1998cited by this paper
• Hereditary Haemochromatosis

  1997cited by this paper
• Long-term survival in patients with hereditary hemochromatosis.

  1996cited by this paper
• Magnetic resonance imaging and assessment of liver iron content in genetic hemochromatosis.

  1992cited by this paper
• Nonalcoholic fatty liver disease.

  1986cited by this paper

• Pathophysiological consequences and benefits of HFE mutations: 20 years of research

  2017cites this paper
• Challenges in diagnosing and monitoring diabetes in patients with chronic liver diseases.

  2017cites this paper
• Identification of new BMP6 pro‐peptide mutations in patients with iron overload

  2017cites this paper
• EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH)

  2015cites this paper
• Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin.

  2015cites this paper
• Abdominelle Sonografie bei Patienten mit Diabetes mellitus. Teil 1: Leber

  2015cites this paper
• Ultrasound in Rare Diffuse Liver Disease

  2014cites this paper
• Author reply

  2013cites this paper
• Design and Validation of a Colorimetric Test for the Genetic Diagnosis of Hemochromatosis Using α-Phosphorothioate Nucleotides

  2013cites this paper
• Contribution à la description phénotypique et à l'étude des patients atteints d'hémochromatose HFE

  2013cites this paper
• Ferritin unit error

  2013cites this paper